Tenaya Therapeutics is trading 7.14% higher at $0.42 in pre-market on October 15, 2026; no confirmed company-specific catalyst for the rise was identified. - Shares fell 25.05% at the October 14 close. - The reverse-split proposal appeared in an October 13 preliminary proxy, not a new announcement today. - Hotter-than-expected U.S. inflation pressured equities and technology shares, while Asian markets fell overnight; this backdrop does not clearly explain the move.